Why Postmortem Testing Matters
Genetic testing following a sudden, unexpected death (including fetal demise or stillbirth) can offer valuable clarity to surviving family members about why their loved one passed away. In addition, confirming an underlying diagnosis with genetic testing can be critical in helping to prevent the same outcome and protect surviving family members.
Samples are often limited in postmortem cases and not all samples types are accepted. Please review our Postmortem Pre-Test Form and Specimen Requirements before submitting samples.
Genetic Counselors Are Available to Help
Please reach out to your local Genomic Science Liaison or call +1 949-900-5500 to discuss postmortem genetic testing options with a genetic counselor at Ambry.
Things to Know Before Testing
Samples and Labeling
- We only accept and attempt testing on a maximum of 2 specimens per patient.
- We no longer accept formalin-fixed, paraffin-embedded (FFPE) tissue blocks, slides, or extracted DNA.
- Submitted samples will likely be exhausted during the postmortem genetic testing process.
- Each specimen and Test Requisition Form must be labeled with the collection date and at least 2 unique patient identifiers.
Testing and Results
- Deletion/duplication analysis cannot be performed on all sample types.
- Turnaround times for postmortem testing results may be slightly extended compared to our standard panels.
Chain of Custody
- Ordering healthcare providers are responsible for adhering to all local Medical Examiner’s or Coroner’s office chain of custody requirements for submitted samples.
Material Retention
- Postmortem materials cannot be returned to ordering providers or forwarded to external labs or biobanks (DNA banking).
Billing
- Testing is restricted to cash or institutional pay only.
Questions? Please review our full Specimen Requirements or contact Ambry Client Solutions at +1 949-900-5500 for assistance.
Postmortem Genetic Testing Options
*Not available on all sample types – refer to Specimen Requirements for details.
CardioNext®
92 Genes
An 92 gene panel that identifies inherited cardiomyopathies, inherited arrhythmias and other inherited cardiovascular conditions.
ABCC9
ACTC1
ACTN2
AKAP9
ALMS1
ALPK3
ANK2
ANKRD1
BAG3
CACNA1C
CACNA2D1
CACNB2
CALM1
CALM2
CALM3
CASQ2
CAV3
CRYAB
CSRP3
DES
DMD
DOLK
DSC2
DSG2
DSP
EMD
EYA4
FHL1
FKRP
FKTN
FLNC
GATAD1
GLA
GPD1L
HCN4
JPH2
JUP
KCND3
KCNE1
KCNE2
KCNE3
KCNH2
KCNJ2
KCNJ5
KCNJ8
KCNQ1
LAMA4
LAMP2
LDB3
LMNA
MYBPC3
MYH6
MYH7
MYL2
MYL3
MYOZ2
MYPN
NEXN
NKX2-5
PKP2
PLN
PRKAG2
PTPN11
RAF1
RBM20
RIT1
RYR2
SCN10A
SCN1B
SCN2B
SCN3B
SCN4B
SCN5A
SNTA1
SOS1
TAZ
TBX20
TBX5
TCAP
TECRL
TGFB3
TMEM43
TNNC1
TNNI3
TNNT2
TPM1
TRDN
TRPM4
TTN
TTR
TXNRD2
VCL
TAADNext®
35 Genes
A next generation sequencing panel that analyzes 35 genes associated with thoracic aortic aneurysms and dissections, Marfan syndrome and related disorders that often contribute to sudden cardiac death. The test can confirm a diagnosis and aid in patient management and treatment options.